Hints and tips:
Showing results for HEALTH MARKET SCIENCE, INC.
Related Special Reports
...The sector is seeing rapid growth that is outpacing much of the UK, said Joann Rhodes, head of the Health Innovation Research Alliance Northern Ireland....
...Dmitry Kuzmin, managing partner of 4Bio Capital, said the past year had brought a “peculiar disconnect” between public markets and appetite for private life sciences investments....
...Concerns over an additional FDA review of donanemab could give Eisai a chance to win greater market share....
...The positive data will also be a boon to Eli Lilly’s efforts to push for more widescale coverage of the drugs by private insurers and US federal health insurance programme Medicare, which were both initially...
...Deaths from the condition have fallen in most high-income states over the past 30 years, partly reflecting public health campaigns and increased testing....
...But it is almost a year since the World Health Organization declared Covid-19 was no longer a global public health emergency, so shouldn’t we have reset by now? Not necessarily, say academics....
...“It shows there is a much wider market.”...
...Pfizer and BioNTech will dispute Moderna’s ability to withdraw the pledge when it did, given the World Health Organization did not declare the end of the “global health emergency” until March 2023....
...The sharp increase, which has prompted several states to declare health emergencies and the Rio de Janeiro government to declare an epidemic, came after health officials warned of a rise in cases due to...
...suggest markets may be underestimating the potential for escalation....
...These firms have the products, the means and the market presence to take action at scale. They also have the scientific knowhow to find innovative new ways of delivering treatment....
...“When you see [GSK’s] two-thirds market share, really taking on not just the market leadership position but a dominant market leadership position, I wouldn’t call that ‘a bit thin’,” said Truckenmiller....
...If science can work out how our sleep switch works, and what controls how long and well we sleep, the practical consequences could be vast. “We will be able to start manipulating this mechanism....
...Authorisation of Xocova for use by standard risk patients has expanded the Covid antivirals market. The market was relatively robust over the summer on the back of a rise in infections....
...A UK biotech start-up has secured $14mn in early-stage funding led by MSD Global Health Innovation Fund to develop vaccines that are “future-proofed” by artificial intelligence....
...“If there is a sense the European market is more complex, of course investors will seek to locate in the US or Asia Pacific region....
...Science, through inoculations, has tamed many diseases that once killed or damaged millions....
...bacteria that pose the greatest threat to human health, not least cancer patients....
...J&J was valued at $367bn, as of market close in New York on Thursday....
Forerunners of pharma company tested vaccines at notorious institutions for decades
...Here, HTSI contributing editor Nicola Moulton speaks with Professor Bader (who famously uses the cream before shaving) and his co-founder and CEO Charles Rosier about adapting the brand for different markets...
...The UK regulator has promised to focus on speeding the most innovative treatments to market after being given permission from next year to cut its workload by following other countries’ recommendations on...
...As more treatments come to market, some worry that societies will become too reliant on them, to the detriment of public health measures. It is a view rejected by Holst....
Pharmaceutical companies scale back development in aftermath of pandemic
...science superpower” by 2030....
International Edition